Evidence map›Paper›PMID 31155757›Full record

ArticleNeuropathology : official journal of the Japanese Society of Neuropathology2019

Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.

Daisuke Ono, Yukiko Shishido-Hara, Saneyuki Mizutani, Yoko Mori, Keiko Ichinose, Mutsufusa Watanabe, Tohru Tanizawa, Takanori Yokota, Toshiki Uchihara, Hiroto Fujigasaki

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Neuropathology : official journal of the Japanese Society of Neuropathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Daisuke OnoDepartment of Internal Medicine, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Yukiko Shishido-HaraLaboratory of Structural Neuropathology, Metropolitan Institute of Medical Science, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4138-1669
Saneyuki MizutaniDepartment of Internal Medicine, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Yoko MoriDepartment of Internal Medicine, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Keiko IchinoseDepartment of Internal Medicine, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Mutsufusa WatanabeDepartment of Internal Medicine, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Tohru TanizawaDepartment of Pathology, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Takanori YokotaDepartment of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Toshiki UchiharaLaboratory of Structural Neuropathology, Metropolitan Institute of Medical Science, Tokyo, Japan.
Hiroto FujigasakiDepartment of Internal Medicine, Metropolitan Bokutoh Hospital, Tokyo, Japan.
Tokyo Metropolitan Bokutoh Hospital · JPTokyo Medical and Dental University · JPTokyo Medical University · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan 18K07397
6 · The paper itself

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder caused by opportunistic infection of JC polyomavirus (JCV). Today, increased attention has been focused on PML development in multiple sclerosis (MS) patients under disease-modifying therapies (DMT). Although in the acquired immunodeficiency syndrome (AIDS) era, PML was thought to be a rapidly progressive disease with poor prognosis, drug-associated PML is relatively slow in progress, and a favorable outcome may be expected with early diagnosis. However, early PML diagnosis on magnetic resonance imaging (MRI) is frequently difficult, and JCV DNA copy number in cerebrospinal fluid (CSF) is usually low. To facilitate early PML diagnosis on MRI, the pre-mortem images were compared with neuropathology of the post-mortem brain, and underlying pathology corresponding to the MRI findings was evaluated. As a result, PML lesions of the autopsied brain were divided into three parts, based on the disease extension patterns: (A) Progressive white matter lesion in the right frontoparietal lobe including the precentral gyrus. Huge demyelinated lesions were formed with fusions of numerous small lesions. (B) Central lesion including deep gray matters, such as the putamen and thalamus. The left thalamic lesion was contiguous with the pontine tegmentum. (C) Infratentorial lesion of brainstem and cerebellum. Demyelination in the pontine basilar region and in cerebellar white matter was contiguous via middle cerebellar peduncles (MCPs). In addition, (D) satellite lesions were scattered all over the brain. These observations indicate that PML lesions likely evolve with three steps in a tract-dependent manner: (1) initiation; (2) extension/expansion of demyelinating lesions; and (3) fusion. Understanding of the PML disease evolution patterns would enable confident early diagnosis on MRI, which is essential for favorable prognosis with good functional outcome.

Indexed as

BrainDisease ProgressionHumansLeukoencephalopathy, Progressive MultifocalMagnetic Resonance ImagingMaleMiddle AgedWhite Matterdisease-modifying therapy (DMT)JC virus (JCV)magnetic resonance imaging (MRI)multiple sclerosis (MS)progressive multifocal leukoencephalopathy (PML)

Identifiers

PMID31155757
PMCPMC6852116
OpenAlexW2948482526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.